KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universal Health Services (UHS) Gains from Sales and Divestitures (2016 - 2024)

Historic Gains from Sales and Divestitures for Universal Health Services (UHS) over the last 16 years, with Q4 2024 value amounting to $1.8 million.

  • Universal Health Services' Gains from Sales and Divestitures fell 1032.83% to $1.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.8 million, marking a year-over-year decrease of 1032.83%. This contributed to the annual value of $1.8 million for FY2024, which is 1032.83% down from last year.
  • According to the latest figures from Q4 2024, Universal Health Services' Gains from Sales and Divestitures is $1.8 million, which was down 1032.83% from $2.0 million recorded in Q4 2023.
  • Over the past 5 years, Universal Health Services' Gains from Sales and Divestitures peaked at $2.2 million during Q4 2021, and registered a low of $1.8 million during Q4 2024.
  • Moreover, its 5-year median value for Gains from Sales and Divestitures was $2.1 million (2022), whereas its average is $2.1 million.
  • In the last 5 years, Universal Health Services' Gains from Sales and Divestitures skyrocketed by 154.47% in 2021 and then tumbled by 1032.83% in 2024.
  • Quarter analysis of 5 years shows Universal Health Services' Gains from Sales and Divestitures stood at $2.2 million in 2020, then increased by 1.54% to $2.2 million in 2021, then decreased by 3.48% to $2.1 million in 2022, then dropped by 7.11% to $2.0 million in 2023, then decreased by 10.33% to $1.8 million in 2024.
  • Its Gains from Sales and Divestitures stands at $1.8 million for Q4 2024, versus $2.0 million for Q4 2023 and $2.1 million for Q4 2022.